Open AccessExpert Panel Consensus for Addressing Anti-VEGF Treatment Challenges of Diabetic Macular Edema in Spain
Author(s) -
José Ignacio FernándezVigo,
Inés Contreras,
María José Crespo,
Carlos Beckford,
Ignacio FloresMoreno,
Rosario Cobo-Soriano,
JA Pareja,
Michael D. Martin,
Luís A. Moreno,
Luis Arrevola-Velasco
Publication year - 2022
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s374763
Subject(s) - aflibercept , medicine , diabetic macular edema , diabetic retinopathy , ranibizumab , ophthalmology , macular edema , visual acuity , bevacizumab , optometry , intensive care medicine , diabetes mellitus , surgery , chemotherapy , endocrinology
The treatment of diabetic macular edema (DME) has evolved rapidly in the past decade, highlighting the need to address the challenges of routine clinical practice decision-making through expert consensus agreements.